COVID-19 Clinical Outcomes and Vaccine Efficacy among Patients with Hematologic Malignancies"> COVID-19 Clinical Outcomes and Vaccine Efficacy among Patients with Hematologic Malignancies">

Loading

logo

Journal of Cellular Immunology

ISSN: 2689-2812

Commentary Open Access
Volume 3 | Issue 5 | DOI: https://doi.org/10.33696/immunology.3.112]

COVID-19 Clinical Outcomes and Vaccine Efficacy among Patients with Hematologic Malignancies

Sarah Gillaspie1,*, Marc S Hoffmann2,*
  • 1niversity of Kansas School of Medicine, 3901 Rainbow Blvd, Kansas City, KS 66160, USA
  • 2Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, 2650 Shawnee Mission Pkwy, Kansas City, KS 66205, USA
+ Affiliations - Affiliations

Corresponding Author

Sarah Gillaspie, sgillaspie@kumc.edu;

Marc S Hoffmann,  mhoffmann@kumc.edu

Received Date: June 18, 2021

Accepted Date: September 22, 2021

Citation:

Gillaspie S, Hoffmann S. COVID-19 Clinical Outcomes and Vaccine Efficacy among Patients with Hematologic Malignancies. J Cell Immunol. 2021; 3(5): 317-320.


Copyright: © 2021 Gillaspie S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Keywords

COVID-19, Hematologic malignancy, Chemotherapy, Lymphopenia, COVID-19 vaccine, Vaccine efficacy

Recommended Articles

Full Text
Cite
Download PDF
Author Information X

About Scientific Archives

Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.

Read More